Towards the Delivery of Precision Veterinary Cancer Medicine
Towards the Delivery of Precision Veterinary Cancer Medicine
复制标题
DOI：
10.1016/j.cvsm.2019.04.011
复制
发表时间：
2019-09-01
影响因子：
1.9
通讯作者：
Khanna, Chand
中科院分区：
文献类型：
--
作者：
Katogiritis, Anna;Khanna, Chand
我们介绍了影响人类和兽医患者的医学发展的下一个阶段。这种演变，基因组癌症医学（Pmed），涉及基因组和分子生物学扩展到临床医学。这些新技术的实施已经开始，并且已经成为商业现实。我们介绍了这种演变的基础，并专注于在复杂疾病状态的应用。宠物主人已经开始要求Pmed技术。为了满足这一需求，重要的是要意识到与可用的Pmed产品相关的机会和障碍，以及该领域的当前状态。
We introduce a next phase in the evolution of medicine affecting human and veterinary patients. This evolution, genomic cancer medicine (Pmed), involves expansion of genomic and molecular biology into clinical medicine. The implementation of these new technologies has already begun and is a commercial reality. We introduce the underpinnings for this evolution, and focus on application in complex disease states. Pet owners have begun requesting Pmed technologies. To meet this demand, it is important to be aware of the opportunities and obstacles associated with available Pmed offerings as well as the current state of the field.